Cara Therapeutics (CARA)
NASDAQ:CARA
Holding CARA?
Track your performance easily

Cara Therapeutics (CARA) Financial Statements

2,256 Followers

Cara Therapeutics Financial Overview

Cara Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.038; its P/E ratio is -0.14; Cara Therapeutics is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 991.00K$ 2.13M$ 4.87M$ 5.41M$ 6.17M
Gross Profit$ -498.00K$ 1.51M$ 3.31M$ 6.93M$ 6.17M
EBIT$ -20.02M$ -28.71M$ -28.90M$ -28.64M$ -26.66M
EBITDA$ -19.17M$ -28.67M$ -28.84M$ -28.16M$ -26.33M
Net Income Common Stockholders$ -20.02M$ -30.70M$ -28.03M$ -31.48M$ -26.66M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 56.62M$ 69.77M$ 78.54M$ 95.10M$ 47.80M
Total Assets$ 72.50M$ 90.10M$ 115.34M$ 134.39M$ 153.28M
Total Debt$ 7.49M$ 7.04M$ 7.31M$ 982.00K$ 77.42M
Net Debt$ -49.13M$ -62.73M$ -71.23M$ -94.12M$ 29.62M
Total Liabilities$ 60.90M$ 60.30M$ 29.70M$ 25.46M$ 92.64M
Stockholders Equity$ 11.60M$ 29.80M$ 85.64M$ 108.93M$ 136.60M
Cash Flow-
Free Cash Flow$ -12.65M$ -31.29M$ -19.97M$ -20.45M$ -34.62M
Operating Cash Flow$ -12.44M$ -30.45M$ -19.64M$ -20.45M$ -34.62M
Investing Cash Flow$ 15.29M$ 25.95M$ 23.16M$ 32.80M$ 17.71M
Financing Cash Flow$ -610.00K$ -685.00K$ 1.12M-$ 560.00K
Currency in USD

Cara Therapeutics Earnings and Revenue History

Cara Therapeutics Debt to Assets

Cara Therapeutics Cash Flow

Cara Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis